Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14% |
| 2 | Energy | 11.19% |
| 3 | Financials | 8.75% |
| 4 | Consumer Discretionary | 8.58% |
| 5 | Industrials | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
McEwen Inc
MUX
$1B
| $947K | ﹤0.01% |
98,767
+5,047
| +5% | +$50.4K |
|
2302
E.W. Scripps
SSP
$270M
| $945K | ﹤0.01% |
+41,347
| New | +$971K |
|
2303
STAAR Surgical
STAA
$1.19B
| $945K | ﹤0.01% |
97,835
-60,917
| -38% | -$565K |
|
2304
PDF Solutions
PDFS
$1.72B
| $944K | ﹤0.01% |
58,983
+25,125
| +74% | +$432K |
|
2305
Usana Health Sciences
USNA
$419M
| $944K | ﹤0.01% |
13,810
-54,296
| -80% | -$3.45M |
|
|
USCR
2306
DELISTED
U S Concrete, Inc.
USCR
| $939K | ﹤0.01% |
24,783
-23,661
| -49% | -$882K |
|
2307
Banco Macro
BMA
$5.81B
| $936K | ﹤0.01% |
+20,523
| New | +$1.09M |
|
|
LION
2308
DELISTED
Fidelity Southern Corporation
LION
| $936K | ﹤0.01% |
53,672
+35,749
| +199% | +$590K |
|
2309
Invesco QQQ Trust
QQQ
$436B
| $935K | ﹤0.01% |
8,735
-55,371
| -86% | -$6.02M |
|
2310
PUT
Cleveland-Cliffs
CLF
$6.49B
| $932K | ﹤0.01% |
215,300
-1,207,800
| -85% | -$6.42M |
|
|
BGFV
2311
DELISTED
Big 5 Sporting Goods
BGFV
| $931K | ﹤0.01% |
65,527
-50,461
| -44% | -$699K |
|
2312
Foster
FSTR
$421M
| $931K | ﹤0.01% |
26,900
+16,472
| +158% | +$673K |
|
|
ASCMA
2313
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $926K | ﹤0.01% |
21,660
-138,289
| -86% | -$5.6M |
|
|
EMBJ
2314
Embraer S.A. ADS
EMBJ
$12B
| $924K | ﹤0.01% |
30,500
-217,228
| -88% | -$6.7M |
|
2315
Aldeyra Therapeutics
ALDX
$97.1M
| $923K | ﹤0.01% |
+119,000
| New | +$1.03M |
|
2316
Semtech
SMTC
$9.65B
| $923K | ﹤0.01% |
+46,480
| New | +$1.08M |
|
|
WFT
2317
CALL
DELISTED
Weatherford International plc
WFT
| $920K | ﹤0.01% |
+75,000
| New | +$1.04M |
|
|
EPIQ
2318
DELISTED
EPIQ SYSTEMS INC
EPIQ
| $914K | ﹤0.01% |
54,141
+37,753
| +230% | +$653K |
|
|
ATXS
2319
DELISTED
Astria Therapeutics
ATXS
| $913K | ﹤0.01% |
+1,247
| New | +$943K |
|
2320
American States Water
AWR
$3.44B
| $911K | ﹤0.01% |
+24,377
| New | +$940K |
|
|
TRIB
2321
Trinity Biotech
TRIB
$8.9M
| $907K | ﹤0.01% |
335
-2,120
| -86% | -$5.51M |
|
|
EVOL
2322
DELISTED
Evolving Systems, Inc.
EVOL
| $907K | ﹤0.01% |
101,250
-8,750
| -8% | -$79.7K |
|
2323
Credit Acceptance
CACC
$5.82B
| $905K | ﹤0.01% |
+3,676
| New | +$814K |
|
2324
Powell Industries
POWL
$6.79B
| $904K | ﹤0.01% |
77,082
+54,318
| +239% | +$649K |
|
|
EGRX
2325
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $902K | ﹤0.01% |
11,154
-23,097
| -67% | -$1.5M |
|
Similar funds
Millennium Management's Q2 2015 Portfolio in Review
As of Q2 2015, Millennium Management held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Millennium Management's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Energy and Financials.
- Millennium Management's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Millennium Management added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Millennium Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Millennium Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Millennium Management's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Millennium Management opened 780 new positions and closed 1,034 in Q2 2015.
- Millennium Management's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.